| Cardiomyopathy |
1 |
1 |
| Amyloidosis |
0 |
0.9 |
| Quality of Life |
0 |
0.8 |
| Heart |
0 |
0.27 |
| Tissue |
0 |
0.27 |
| B-Type Natriuretic Peptide |
0 |
0.19 |
| Muscle Spasm |
0 |
0.19 |
| Heart Failure (HF) |
0 |
0.14 |
| Arthralgia |
0 |
0.13 |
| Brain |
0 |
0.13 |
| Canada |
0 |
0.13 |
| Clinical Research |
0 |
0.13 |
| Europe |
0 |
0.13 |
| Interference |
0 |
0.13 |
| Kansas |
0 |
0.13 |
| Muscle |
0 |
0.13 |
| Nerve |
0 |
0.13 |
| New York |
0 |
0.13 |
| Stress |
0 |
0.13 |
| Healthcare and Medical Technology |
0 |
0.04 |
| Myocardial Infarction (MI) |
0 |
0.04 |